Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Adipose-derived stem cells show potential for skin rejuvenation and wound healing but require more research to overcome challenges and ensure safety.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

PDCD4 is important for controlling skin cell growth and healing.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Bald men may have a lower risk of testicular cancer.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

A woman with a rare scalp lymphoma had unusual hair loss after treatment.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3 levels, suggesting these factors might influence male pattern baldness.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

Hair follicle pores help cell survival and growth, even after radiation.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Syphilis is becoming more common and remains a major health problem due to challenges in prevention and treatment.

Regulating certain sex hormones may help delay facial aging.

Advanced imaging techniques are crucial for accurately diagnosing Monilethrix, a rare hair disorder.